Allopregnanolone Decreases Evoked Dopamine Release Differently in Rats by Sex and Estrous Stage
Mesolimbic dopamine transmission is dysregulated in multiple psychiatric disorders, including addiction. Previous studies found that the endogenous GABAergic steroid (3α,5α)-3-hydroxy-5-pregnan-20-one (allopregnanolone) modulates dopamine levels in the nucleus accumbens and prefrontal cortex. As all...
Saved in:
Main Authors: | Ana Paula S. Dornellas (Author), Giovana C. Macedo (Author), Minna H. McFarland (Author), Alexander Gómez-A (Author), Todd K. O'Buckley (Author), Claudio Da Cunha (Author), A. Leslie Morrow (Author), Donita L. Robinson (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Allopregnanolone alters follicular and luteal dynamics during the estrous cycle
by: Joana Antonela Asensio, et al.
Published: (2018) -
Allopregnanolone in Postpartum Depression
by: Graziano Pinna, et al.
Published: (2022) -
Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders
by: Walkery A, et al.
Published: (2021) -
PENGARUH SELF-TALK TERHADAP KEPERCAYAAN DIRI PADA ATLET PANAHAN REMAJA
by: Donita Nawangayu Ningsih, -
Published: (2023) -
Buprenorphine is a weak dopamine releaser relative to heroin, but its pretreatment attenuates heroin‐evoked dopamine release in rats
by: Dominic P. Isaacs, et al.
Published: (2020)